RCM
EW icon

Roc Capital Management’s Edwards Lifesciences EW Stock Holding History

Roc Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$345K Buy
+30,792
New +$364K 1.09% 36

Other funds holding EW

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Roc Capital Management's EW Position: Q2 2013 in Review

Roc Capital Management opened a new position in Edwards Lifesciences (EW) in Q2 2013: 30,792 shares worth $345K. The stake represents 1.09% of the portfolio and ranks #36 among its holdings.

375 funds tracked by Wall St. Rank hold EW as of Q2 2013.

  • Roc Capital Management held 30,792 shares of Edwards Lifesciences worth $345K as of Q2 2013.
  • Edwards Lifesciences was a new Roc Capital Management position in Q2 2013.
  • Edwards Lifesciences made up 1.09% of Roc Capital Management's portfolio in Q2 2013, its #36 holding.
  • 375 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2013.

Based on Roc Capital Management's 13F filing for Q2 2013, filed 7 Aug 2013.